nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—UGT2B7—Ezetimibe—atherosclerosis	0.0723	0.0953	CbGbCtD
Carbamazepine—UGT2B7—Simvastatin—atherosclerosis	0.0672	0.0886	CbGbCtD
Carbamazepine—UGT2B7—Lovastatin—atherosclerosis	0.0658	0.0867	CbGbCtD
Carbamazepine—ABCC2—Ezetimibe—atherosclerosis	0.038	0.0501	CbGbCtD
Carbamazepine—ABCC2—Simvastatin—atherosclerosis	0.0353	0.0466	CbGbCtD
Carbamazepine—ABCC2—Lovastatin—atherosclerosis	0.0346	0.0456	CbGbCtD
Carbamazepine—ABCC2—Pravastatin—atherosclerosis	0.0346	0.0456	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0236	0.0311	CbGbCtD
Carbamazepine—CYP3A7—Simvastatin—atherosclerosis	0.0236	0.0311	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0231	0.0304	CbGbCtD
Carbamazepine—CYP3A7—Lovastatin—atherosclerosis	0.0231	0.0304	CbGbCtD
Carbamazepine—CYP2B6—Simvastatin—atherosclerosis	0.0225	0.0296	CbGbCtD
Carbamazepine—CYP3A5—Rosuvastatin—atherosclerosis	0.019	0.0251	CbGbCtD
Carbamazepine—CYP3A5—Simvastatin—atherosclerosis	0.0177	0.0233	CbGbCtD
Carbamazepine—CYP3A5—Lovastatin—atherosclerosis	0.0173	0.0228	CbGbCtD
Carbamazepine—CYP3A5—Pravastatin—atherosclerosis	0.0173	0.0228	CbGbCtD
Carbamazepine—CYP2C8—Simvastatin—atherosclerosis	0.017	0.0224	CbGbCtD
Carbamazepine—CYP2C8—Pravastatin—atherosclerosis	0.0167	0.022	CbGbCtD
Carbamazepine—CYP2C8—Lovastatin—atherosclerosis	0.0167	0.022	CbGbCtD
Carbamazepine—CYP2C19—Rosuvastatin—atherosclerosis	0.0154	0.0202	CbGbCtD
Carbamazepine—CYP2C19—Simvastatin—atherosclerosis	0.0143	0.0188	CbGbCtD
Carbamazepine—CYP2C19—Lovastatin—atherosclerosis	0.014	0.0184	CbGbCtD
Carbamazepine—CYP2C9—Rosuvastatin—atherosclerosis	0.0128	0.0168	CbGbCtD
Carbamazepine—ABCB1—Ezetimibe—atherosclerosis	0.0124	0.0163	CbGbCtD
Carbamazepine—CYP2C9—Simvastatin—atherosclerosis	0.0119	0.0156	CbGbCtD
Carbamazepine—CYP2C9—Pravastatin—atherosclerosis	0.0116	0.0153	CbGbCtD
Carbamazepine—CYP2C9—Lovastatin—atherosclerosis	0.0116	0.0153	CbGbCtD
Carbamazepine—ABCB1—Simvastatin—atherosclerosis	0.0115	0.0152	CbGbCtD
Carbamazepine—ABCB1—Lovastatin—atherosclerosis	0.0113	0.0149	CbGbCtD
Carbamazepine—ABCB1—Pravastatin—atherosclerosis	0.0113	0.0149	CbGbCtD
Carbamazepine—CYP3A4—Ezetimibe—atherosclerosis	0.00742	0.00979	CbGbCtD
Carbamazepine—CYP3A4—Rosuvastatin—atherosclerosis	0.00742	0.00979	CbGbCtD
Carbamazepine—CYP3A4—Simvastatin—atherosclerosis	0.0069	0.0091	CbGbCtD
Carbamazepine—CYP3A4—Pravastatin—atherosclerosis	0.00675	0.0089	CbGbCtD
Carbamazepine—CYP3A4—Lovastatin—atherosclerosis	0.00675	0.0089	CbGbCtD
Carbamazepine—Methdilazine—HRH1—atherosclerosis	0.000795	0.172	CrCbGaD
Carbamazepine—Alimemazine—HRH1—atherosclerosis	0.00058	0.125	CrCbGaD
Carbamazepine—Epinastine—HRH1—atherosclerosis	0.00053	0.114	CrCbGaD
Carbamazepine—Cyproheptadine—HRH1—atherosclerosis	0.000405	0.0874	CrCbGaD
Carbamazepine—Muscle spasms—Ezetimibe—atherosclerosis	0.000269	0.00151	CcSEcCtD
Carbamazepine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000269	0.00151	CcSEcCtD
Carbamazepine—Vision blurred—Lovastatin—atherosclerosis	0.000269	0.00151	CcSEcCtD
Carbamazepine—Mental disorder—Simvastatin—atherosclerosis	0.000269	0.00151	CcSEcCtD
Carbamazepine—Tremor—Lovastatin—atherosclerosis	0.000268	0.0015	CcSEcCtD
Carbamazepine—Erythema—Simvastatin—atherosclerosis	0.000267	0.0015	CcSEcCtD
Carbamazepine—Eye disorder—Niacin—atherosclerosis	0.000263	0.00148	CcSEcCtD
Carbamazepine—Tinnitus—Niacin—atherosclerosis	0.000263	0.00148	CcSEcCtD
Carbamazepine—Erythema multiforme—Pravastatin—atherosclerosis	0.000262	0.00148	CcSEcCtD
Carbamazepine—Dysgeusia—Simvastatin—atherosclerosis	0.000262	0.00147	CcSEcCtD
Carbamazepine—Flushing—Niacin—atherosclerosis	0.000262	0.00147	CcSEcCtD
Carbamazepine—Angioedema—Lovastatin—atherosclerosis	0.000261	0.00147	CcSEcCtD
Carbamazepine—Anaemia—Ezetimibe—atherosclerosis	0.000259	0.00146	CcSEcCtD
Carbamazepine—Tinnitus—Pravastatin—atherosclerosis	0.000259	0.00145	CcSEcCtD
Carbamazepine—Trimipramine—HRH1—atherosclerosis	0.000258	0.0557	CrCbGaD
Carbamazepine—Flushing—Pravastatin—atherosclerosis	0.000258	0.00145	CcSEcCtD
Carbamazepine—Cardiac disorder—Pravastatin—atherosclerosis	0.000258	0.00145	CcSEcCtD
Carbamazepine—Muscle spasms—Simvastatin—atherosclerosis	0.000257	0.00144	CcSEcCtD
Carbamazepine—Vertigo—Lovastatin—atherosclerosis	0.000257	0.00144	CcSEcCtD
Carbamazepine—Angioedema—Ezetimibe—atherosclerosis	0.000256	0.00144	CcSEcCtD
Carbamazepine—Angiopathy—Niacin—atherosclerosis	0.000256	0.00144	CcSEcCtD
Carbamazepine—Leukopenia—Lovastatin—atherosclerosis	0.000256	0.00144	CcSEcCtD
Carbamazepine—Chills—Niacin—atherosclerosis	0.000253	0.00142	CcSEcCtD
Carbamazepine—Vision blurred—Simvastatin—atherosclerosis	0.000252	0.00142	CcSEcCtD
Carbamazepine—Arrhythmia—Niacin—atherosclerosis	0.000252	0.00142	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000251	0.00141	CcSEcCtD
Carbamazepine—Tremor—Simvastatin—atherosclerosis	0.00025	0.00141	CcSEcCtD
Carbamazepine—Alopecia—Niacin—atherosclerosis	0.000249	0.0014	CcSEcCtD
Carbamazepine—Chills—Pravastatin—atherosclerosis	0.000249	0.0014	CcSEcCtD
Carbamazepine—Insomnia—Rosuvastatin—atherosclerosis	0.000249	0.0014	CcSEcCtD
Carbamazepine—Promethazine—HRH1—atherosclerosis	0.000249	0.0537	CrCbGaD
Carbamazepine—Arrhythmia—Pravastatin—atherosclerosis	0.000248	0.00139	CcSEcCtD
Carbamazepine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000247	0.00139	CcSEcCtD
Carbamazepine—Anaemia—Simvastatin—atherosclerosis	0.000247	0.00139	CcSEcCtD
Carbamazepine—Malnutrition—Niacin—atherosclerosis	0.000245	0.00138	CcSEcCtD
Carbamazepine—Erythema—Niacin—atherosclerosis	0.000245	0.00138	CcSEcCtD
Carbamazepine—Alopecia—Pravastatin—atherosclerosis	0.000245	0.00138	CcSEcCtD
Carbamazepine—Angioedema—Simvastatin—atherosclerosis	0.000244	0.00137	CcSEcCtD
Carbamazepine—Myalgia—Lovastatin—atherosclerosis	0.000243	0.00137	CcSEcCtD
Carbamazepine—Arthralgia—Lovastatin—atherosclerosis	0.000243	0.00137	CcSEcCtD
Carbamazepine—Chest pain—Lovastatin—atherosclerosis	0.000243	0.00137	CcSEcCtD
Carbamazepine—Anxiety—Lovastatin—atherosclerosis	0.000242	0.00136	CcSEcCtD
Carbamazepine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000242	0.00136	CcSEcCtD
Carbamazepine—Hypertension—Ezetimibe—atherosclerosis	0.000242	0.00136	CcSEcCtD
Carbamazepine—Tension—Niacin—atherosclerosis	0.000241	0.00135	CcSEcCtD
Carbamazepine—Vertigo—Simvastatin—atherosclerosis	0.00024	0.00135	CcSEcCtD
Carbamazepine—Leukopenia—Simvastatin—atherosclerosis	0.000239	0.00134	CcSEcCtD
Carbamazepine—Myalgia—Ezetimibe—atherosclerosis	0.000239	0.00134	CcSEcCtD
Carbamazepine—Arthralgia—Ezetimibe—atherosclerosis	0.000239	0.00134	CcSEcCtD
Carbamazepine—Chest pain—Ezetimibe—atherosclerosis	0.000239	0.00134	CcSEcCtD
Carbamazepine—Nervousness—Niacin—atherosclerosis	0.000238	0.00134	CcSEcCtD
Carbamazepine—Dry mouth—Lovastatin—atherosclerosis	0.000238	0.00134	CcSEcCtD
Carbamazepine—Tension—Pravastatin—atherosclerosis	0.000237	0.00133	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000237	0.00133	CcSEcCtD
Carbamazepine—Dysgeusia—Pravastatin—atherosclerosis	0.000237	0.00133	CcSEcCtD
Carbamazepine—Muscle spasms—Niacin—atherosclerosis	0.000236	0.00133	CcSEcCtD
Carbamazepine—Constipation—Rosuvastatin—atherosclerosis	0.000235	0.00132	CcSEcCtD
Carbamazepine—Pain—Rosuvastatin—atherosclerosis	0.000235	0.00132	CcSEcCtD
Carbamazepine—Confusional state—Lovastatin—atherosclerosis	0.000235	0.00132	CcSEcCtD
Carbamazepine—Nervousness—Pravastatin—atherosclerosis	0.000235	0.00132	CcSEcCtD
Carbamazepine—Dry mouth—Ezetimibe—atherosclerosis	0.000233	0.00131	CcSEcCtD
Carbamazepine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000233	0.00131	CcSEcCtD
Carbamazepine—Muscle spasms—Pravastatin—atherosclerosis	0.000232	0.00131	CcSEcCtD
Carbamazepine—Infection—Lovastatin—atherosclerosis	0.000232	0.0013	CcSEcCtD
Carbamazepine—Vision blurred—Niacin—atherosclerosis	0.000231	0.0013	CcSEcCtD
Carbamazepine—Confusional state—Ezetimibe—atherosclerosis	0.000231	0.0013	CcSEcCtD
Carbamazepine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000229	0.00129	CcSEcCtD
Carbamazepine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000228	0.00128	CcSEcCtD
Carbamazepine—Vision blurred—Pravastatin—atherosclerosis	0.000228	0.00128	CcSEcCtD
Carbamazepine—Arthralgia—Simvastatin—atherosclerosis	0.000228	0.00128	CcSEcCtD
Carbamazepine—Chest pain—Simvastatin—atherosclerosis	0.000228	0.00128	CcSEcCtD
Carbamazepine—Myalgia—Simvastatin—atherosclerosis	0.000228	0.00128	CcSEcCtD
Carbamazepine—Infection—Ezetimibe—atherosclerosis	0.000227	0.00128	CcSEcCtD
Carbamazepine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000227	0.00127	CcSEcCtD
Carbamazepine—Anxiety—Simvastatin—atherosclerosis	0.000227	0.00127	CcSEcCtD
Carbamazepine—Tremor—Pravastatin—atherosclerosis	0.000226	0.00127	CcSEcCtD
Carbamazepine—Desipramine—HRH1—atherosclerosis	0.000226	0.0487	CrCbGaD
Carbamazepine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000225	0.00126	CcSEcCtD
Carbamazepine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000224	0.00126	CcSEcCtD
Carbamazepine—Angioedema—Niacin—atherosclerosis	0.000224	0.00126	CcSEcCtD
Carbamazepine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000224	0.00126	CcSEcCtD
Carbamazepine—Anaemia—Pravastatin—atherosclerosis	0.000223	0.00126	CcSEcCtD
Carbamazepine—Anorexia—Lovastatin—atherosclerosis	0.000222	0.00125	CcSEcCtD
Carbamazepine—Skin disorder—Ezetimibe—atherosclerosis	0.000222	0.00125	CcSEcCtD
Carbamazepine—Angioedema—Pravastatin—atherosclerosis	0.000221	0.00124	CcSEcCtD
Carbamazepine—Vertigo—Niacin—atherosclerosis	0.00022	0.00124	CcSEcCtD
Carbamazepine—Syncope—Niacin—atherosclerosis	0.00022	0.00124	CcSEcCtD
Carbamazepine—Confusional state—Simvastatin—atherosclerosis	0.00022	0.00124	CcSEcCtD
Carbamazepine—Nepafenac—PTGS2—atherosclerosis	0.00022	0.0475	CrCbGaD
Carbamazepine—Leukopenia—Niacin—atherosclerosis	0.00022	0.00123	CcSEcCtD
Carbamazepine—Promazine—HRH1—atherosclerosis	0.000219	0.0472	CrCbGaD
Carbamazepine—Urticaria—Rosuvastatin—atherosclerosis	0.000219	0.00123	CcSEcCtD
Carbamazepine—Oedema—Simvastatin—atherosclerosis	0.000218	0.00123	CcSEcCtD
Carbamazepine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000218	0.00123	CcSEcCtD
Carbamazepine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000218	0.00122	CcSEcCtD
Carbamazepine—Vertigo—Pravastatin—atherosclerosis	0.000217	0.00122	CcSEcCtD
Carbamazepine—Infection—Simvastatin—atherosclerosis	0.000217	0.00122	CcSEcCtD
Carbamazepine—Leukopenia—Pravastatin—atherosclerosis	0.000216	0.00122	CcSEcCtD
Carbamazepine—Loss of consciousness—Niacin—atherosclerosis	0.000216	0.00121	CcSEcCtD
Carbamazepine—Magnesium salicylate—PTGS2—atherosclerosis	0.000215	0.0464	CrCbGaD
Carbamazepine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000214	0.0012	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000212	0.00119	CcSEcCtD
Carbamazepine—Insomnia—Lovastatin—atherosclerosis	0.000211	0.00119	CcSEcCtD
Carbamazepine—Paraesthesia—Lovastatin—atherosclerosis	0.000209	0.00118	CcSEcCtD
Carbamazepine—Arthralgia—Niacin—atherosclerosis	0.000209	0.00117	CcSEcCtD
Carbamazepine—Myalgia—Niacin—atherosclerosis	0.000209	0.00117	CcSEcCtD
Carbamazepine—Hypertension—Pravastatin—atherosclerosis	0.000209	0.00117	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000208	0.00117	CcSEcCtD
Carbamazepine—Anorexia—Simvastatin—atherosclerosis	0.000208	0.00117	CcSEcCtD
Carbamazepine—Dyspnoea—Lovastatin—atherosclerosis	0.000208	0.00117	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000207	0.00117	CcSEcCtD
Carbamazepine—Insomnia—Ezetimibe—atherosclerosis	0.000207	0.00116	CcSEcCtD
Carbamazepine—Arthralgia—Pravastatin—atherosclerosis	0.000206	0.00116	CcSEcCtD
Carbamazepine—Chest pain—Pravastatin—atherosclerosis	0.000206	0.00116	CcSEcCtD
Carbamazepine—Myalgia—Pravastatin—atherosclerosis	0.000206	0.00116	CcSEcCtD
Carbamazepine—Paraesthesia—Ezetimibe—atherosclerosis	0.000205	0.00115	CcSEcCtD
Carbamazepine—Dyspepsia—Lovastatin—atherosclerosis	0.000205	0.00115	CcSEcCtD
Carbamazepine—Anxiety—Pravastatin—atherosclerosis	0.000205	0.00115	CcSEcCtD
Carbamazepine—Dry mouth—Niacin—atherosclerosis	0.000204	0.00115	CcSEcCtD
Carbamazepine—Dyspnoea—Ezetimibe—atherosclerosis	0.000204	0.00115	CcSEcCtD
Carbamazepine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000203	0.00114	CcSEcCtD
Carbamazepine—Decreased appetite—Lovastatin—atherosclerosis	0.000203	0.00114	CcSEcCtD
Carbamazepine—Dyspepsia—Ezetimibe—atherosclerosis	0.000201	0.00113	CcSEcCtD
Carbamazepine—Fatigue—Lovastatin—atherosclerosis	0.000201	0.00113	CcSEcCtD
Carbamazepine—Oedema—Niacin—atherosclerosis	0.0002	0.00113	CcSEcCtD
Carbamazepine—Anaphylactic shock—Niacin—atherosclerosis	0.0002	0.00113	CcSEcCtD
Carbamazepine—Pain—Lovastatin—atherosclerosis	0.000199	0.00112	CcSEcCtD
Carbamazepine—Constipation—Lovastatin—atherosclerosis	0.000199	0.00112	CcSEcCtD
Carbamazepine—Confusional state—Pravastatin—atherosclerosis	0.000199	0.00112	CcSEcCtD
Carbamazepine—Decreased appetite—Ezetimibe—atherosclerosis	0.000199	0.00112	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000199	0.00112	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000197	0.00111	CcSEcCtD
Carbamazepine—Asthenia—Rosuvastatin—atherosclerosis	0.000197	0.00111	CcSEcCtD
Carbamazepine—Insomnia—Simvastatin—atherosclerosis	0.000197	0.00111	CcSEcCtD
Carbamazepine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000197	0.00111	CcSEcCtD
Carbamazepine—Oedema—Pravastatin—atherosclerosis	0.000197	0.00111	CcSEcCtD
Carbamazepine—Fatigue—Ezetimibe—atherosclerosis	0.000197	0.00111	CcSEcCtD
Carbamazepine—Shock—Niacin—atherosclerosis	0.000197	0.00111	CcSEcCtD
Carbamazepine—Infection—Pravastatin—atherosclerosis	0.000196	0.0011	CcSEcCtD
Carbamazepine—Paraesthesia—Simvastatin—atherosclerosis	0.000196	0.0011	CcSEcCtD
Carbamazepine—Pain—Ezetimibe—atherosclerosis	0.000196	0.0011	CcSEcCtD
Carbamazepine—Constipation—Ezetimibe—atherosclerosis	0.000196	0.0011	CcSEcCtD
Carbamazepine—Tachycardia—Niacin—atherosclerosis	0.000195	0.0011	CcSEcCtD
Carbamazepine—Pruritus—Rosuvastatin—atherosclerosis	0.000195	0.00109	CcSEcCtD
Carbamazepine—Skin disorder—Niacin—atherosclerosis	0.000195	0.00109	CcSEcCtD
Carbamazepine—Dyspnoea—Simvastatin—atherosclerosis	0.000194	0.00109	CcSEcCtD
Carbamazepine—Hyperhidrosis—Niacin—atherosclerosis	0.000194	0.00109	CcSEcCtD
Carbamazepine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000193	0.00109	CcSEcCtD
Carbamazepine—Feeling abnormal—Lovastatin—atherosclerosis	0.000192	0.00108	CcSEcCtD
Carbamazepine—Dyspepsia—Simvastatin—atherosclerosis	0.000192	0.00108	CcSEcCtD
Carbamazepine—Imipramine—HRH1—atherosclerosis	0.000191	0.0413	CrCbGaD
Carbamazepine—Magnesium salicylate—ALB—atherosclerosis	0.000191	0.0413	CrCbGaD
Carbamazepine—Anorexia—Niacin—atherosclerosis	0.000191	0.00107	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000191	0.00107	CcSEcCtD
Carbamazepine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000191	0.00107	CcSEcCtD
Carbamazepine—Decreased appetite—Simvastatin—atherosclerosis	0.00019	0.00107	CcSEcCtD
Carbamazepine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000188	0.00106	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000188	0.00106	CcSEcCtD
Carbamazepine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000188	0.00106	CcSEcCtD
Carbamazepine—Fatigue—Simvastatin—atherosclerosis	0.000188	0.00106	CcSEcCtD
Carbamazepine—Anorexia—Pravastatin—atherosclerosis	0.000188	0.00106	CcSEcCtD
Carbamazepine—Hypotension—Niacin—atherosclerosis	0.000187	0.00105	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000187	0.00105	CcSEcCtD
Carbamazepine—Constipation—Simvastatin—atherosclerosis	0.000187	0.00105	CcSEcCtD
Carbamazepine—Pain—Simvastatin—atherosclerosis	0.000187	0.00105	CcSEcCtD
Carbamazepine—Urticaria—Lovastatin—atherosclerosis	0.000185	0.00104	CcSEcCtD
Carbamazepine—Abdominal pain—Lovastatin—atherosclerosis	0.000184	0.00104	CcSEcCtD
Carbamazepine—Body temperature increased—Lovastatin—atherosclerosis	0.000184	0.00104	CcSEcCtD
Carbamazepine—Salsalate—PTGS2—atherosclerosis	0.000183	0.0394	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—atherosclerosis	0.000183	0.0394	CrCbGaD
Carbamazepine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000182	0.00103	CcSEcCtD
Carbamazepine—Dizziness—Rosuvastatin—atherosclerosis	0.000182	0.00102	CcSEcCtD
Carbamazepine—Urticaria—Ezetimibe—atherosclerosis	0.000182	0.00102	CcSEcCtD
Carbamazepine—Insomnia—Niacin—atherosclerosis	0.000181	0.00102	CcSEcCtD
Carbamazepine—Body temperature increased—Ezetimibe—atherosclerosis	0.000181	0.00102	CcSEcCtD
Carbamazepine—Abdominal pain—Ezetimibe—atherosclerosis	0.000181	0.00102	CcSEcCtD
Carbamazepine—Paraesthesia—Niacin—atherosclerosis	0.00018	0.00101	CcSEcCtD
Carbamazepine—Feeling abnormal—Simvastatin—atherosclerosis	0.00018	0.00101	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00018	0.00101	CcSEcCtD
Carbamazepine—Dyspnoea—Niacin—atherosclerosis	0.000179	0.001	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000178	0.001	CcSEcCtD
Carbamazepine—Insomnia—Pravastatin—atherosclerosis	0.000178	0.001	CcSEcCtD
Carbamazepine—Somnolence—Niacin—atherosclerosis	0.000178	0.001	CcSEcCtD
Carbamazepine—Paraesthesia—Pravastatin—atherosclerosis	0.000177	0.000995	CcSEcCtD
Carbamazepine—Dyspepsia—Niacin—atherosclerosis	0.000176	0.000991	CcSEcCtD
Carbamazepine—Dyspnoea—Pravastatin—atherosclerosis	0.000176	0.000988	CcSEcCtD
Carbamazepine—Decreased appetite—Niacin—atherosclerosis	0.000174	0.000979	CcSEcCtD
Carbamazepine—Dyspepsia—Pravastatin—atherosclerosis	0.000174	0.000976	CcSEcCtD
Carbamazepine—Rash—Rosuvastatin—atherosclerosis	0.000174	0.000975	CcSEcCtD
Carbamazepine—Dermatitis—Rosuvastatin—atherosclerosis	0.000173	0.000974	CcSEcCtD
Carbamazepine—Urticaria—Simvastatin—atherosclerosis	0.000173	0.000974	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000173	0.000972	CcSEcCtD
Carbamazepine—Abdominal pain—Simvastatin—atherosclerosis	0.000172	0.000969	CcSEcCtD
Carbamazepine—Body temperature increased—Simvastatin—atherosclerosis	0.000172	0.000969	CcSEcCtD
Carbamazepine—Headache—Rosuvastatin—atherosclerosis	0.000172	0.000969	CcSEcCtD
Carbamazepine—Hypersensitivity—Lovastatin—atherosclerosis	0.000172	0.000966	CcSEcCtD
Carbamazepine—Decreased appetite—Pravastatin—atherosclerosis	0.000171	0.000964	CcSEcCtD
Carbamazepine—Pain—Niacin—atherosclerosis	0.000171	0.000963	CcSEcCtD
Carbamazepine—Fatigue—Pravastatin—atherosclerosis	0.00017	0.000956	CcSEcCtD
Carbamazepine—Pain—Pravastatin—atherosclerosis	0.000169	0.000948	CcSEcCtD
Carbamazepine—Constipation—Pravastatin—atherosclerosis	0.000169	0.000948	CcSEcCtD
Carbamazepine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000169	0.000947	CcSEcCtD
Carbamazepine—Asthenia—Lovastatin—atherosclerosis	0.000167	0.000941	CcSEcCtD
Carbamazepine—Pruritus—Lovastatin—atherosclerosis	0.000165	0.000927	CcSEcCtD
Carbamazepine—Asthenia—Ezetimibe—atherosclerosis	0.000164	0.000923	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Niacin—atherosclerosis	0.000164	0.000921	CcSEcCtD
Carbamazepine—Nausea—Rosuvastatin—atherosclerosis	0.000163	0.000919	CcSEcCtD
Carbamazepine—Feeling abnormal—Pravastatin—atherosclerosis	0.000163	0.000914	CcSEcCtD
Carbamazepine—Pruritus—Ezetimibe—atherosclerosis	0.000162	0.00091	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000161	0.000907	CcSEcCtD
Carbamazepine—Hypersensitivity—Simvastatin—atherosclerosis	0.000161	0.000903	CcSEcCtD
Carbamazepine—Diarrhoea—Lovastatin—atherosclerosis	0.00016	0.000897	CcSEcCtD
Carbamazepine—Urticaria—Niacin—atherosclerosis	0.000159	0.000894	CcSEcCtD
Carbamazepine—Abdominal pain—Niacin—atherosclerosis	0.000158	0.00089	CcSEcCtD
Carbamazepine—Body temperature increased—Niacin—atherosclerosis	0.000158	0.00089	CcSEcCtD
Carbamazepine—Urticaria—Pravastatin—atherosclerosis	0.000157	0.000881	CcSEcCtD
Carbamazepine—Asthenia—Simvastatin—atherosclerosis	0.000156	0.00088	CcSEcCtD
Carbamazepine—Diarrhoea—Ezetimibe—atherosclerosis	0.000156	0.00088	CcSEcCtD
Carbamazepine—Body temperature increased—Pravastatin—atherosclerosis	0.000156	0.000876	CcSEcCtD
Carbamazepine—Abdominal pain—Pravastatin—atherosclerosis	0.000156	0.000876	CcSEcCtD
Carbamazepine—Pruritus—Simvastatin—atherosclerosis	0.000154	0.000868	CcSEcCtD
Carbamazepine—Dizziness—Lovastatin—atherosclerosis	0.000154	0.000867	CcSEcCtD
Carbamazepine—Dizziness—Ezetimibe—atherosclerosis	0.000151	0.00085	CcSEcCtD
Carbamazepine—Diarrhoea—Simvastatin—atherosclerosis	0.000149	0.000839	CcSEcCtD
Carbamazepine—Vomiting—Lovastatin—atherosclerosis	0.000148	0.000834	CcSEcCtD
Carbamazepine—Hypersensitivity—Niacin—atherosclerosis	0.000148	0.00083	CcSEcCtD
Carbamazepine—Rash—Lovastatin—atherosclerosis	0.000147	0.000827	CcSEcCtD
Carbamazepine—Dermatitis—Lovastatin—atherosclerosis	0.000147	0.000826	CcSEcCtD
Carbamazepine—Headache—Lovastatin—atherosclerosis	0.000146	0.000821	CcSEcCtD
Carbamazepine—Vomiting—Ezetimibe—atherosclerosis	0.000145	0.000818	CcSEcCtD
Carbamazepine—Hypersensitivity—Pravastatin—atherosclerosis	0.000145	0.000817	CcSEcCtD
Carbamazepine—Dizziness—Simvastatin—atherosclerosis	0.000144	0.000811	CcSEcCtD
Carbamazepine—Rash—Ezetimibe—atherosclerosis	0.000144	0.000811	CcSEcCtD
Carbamazepine—Dermatitis—Ezetimibe—atherosclerosis	0.000144	0.00081	CcSEcCtD
Carbamazepine—Asthenia—Niacin—atherosclerosis	0.000144	0.000808	CcSEcCtD
Carbamazepine—Headache—Ezetimibe—atherosclerosis	0.000143	0.000805	CcSEcCtD
Carbamazepine—Pruritus—Niacin—atherosclerosis	0.000142	0.000797	CcSEcCtD
Carbamazepine—Asthenia—Pravastatin—atherosclerosis	0.000141	0.000795	CcSEcCtD
Carbamazepine—Pruritus—Pravastatin—atherosclerosis	0.00014	0.000784	CcSEcCtD
Carbamazepine—Vomiting—Simvastatin—atherosclerosis	0.000139	0.00078	CcSEcCtD
Carbamazepine—Nausea—Lovastatin—atherosclerosis	0.000139	0.000779	CcSEcCtD
Carbamazepine—Rash—Simvastatin—atherosclerosis	0.000138	0.000773	CcSEcCtD
Carbamazepine—Dermatitis—Simvastatin—atherosclerosis	0.000137	0.000772	CcSEcCtD
Carbamazepine—Diarrhoea—Niacin—atherosclerosis	0.000137	0.00077	CcSEcCtD
Carbamazepine—Headache—Simvastatin—atherosclerosis	0.000137	0.000768	CcSEcCtD
Carbamazepine—Nausea—Ezetimibe—atherosclerosis	0.000136	0.000764	CcSEcCtD
Carbamazepine—Diarrhoea—Pravastatin—atherosclerosis	0.000135	0.000758	CcSEcCtD
Carbamazepine—Dizziness—Niacin—atherosclerosis	0.000132	0.000745	CcSEcCtD
Carbamazepine—Dizziness—Pravastatin—atherosclerosis	0.00013	0.000733	CcSEcCtD
Carbamazepine—Nausea—Simvastatin—atherosclerosis	0.00013	0.000728	CcSEcCtD
Carbamazepine—Vomiting—Niacin—atherosclerosis	0.000127	0.000716	CcSEcCtD
Carbamazepine—Rash—Niacin—atherosclerosis	0.000126	0.00071	CcSEcCtD
Carbamazepine—Dermatitis—Niacin—atherosclerosis	0.000126	0.000709	CcSEcCtD
Carbamazepine—Headache—Niacin—atherosclerosis	0.000125	0.000705	CcSEcCtD
Carbamazepine—Vomiting—Pravastatin—atherosclerosis	0.000125	0.000705	CcSEcCtD
Carbamazepine—Rash—Pravastatin—atherosclerosis	0.000124	0.000699	CcSEcCtD
Carbamazepine—Dermatitis—Pravastatin—atherosclerosis	0.000124	0.000698	CcSEcCtD
Carbamazepine—Headache—Pravastatin—atherosclerosis	0.000124	0.000694	CcSEcCtD
Carbamazepine—Nausea—Niacin—atherosclerosis	0.000119	0.000669	CcSEcCtD
Carbamazepine—Nausea—Pravastatin—atherosclerosis	0.000117	0.000658	CcSEcCtD
Carbamazepine—Oxcarbazepine—ALB—atherosclerosis	0.000113	0.0244	CrCbGaD
Carbamazepine—Phenytoin—ALB—atherosclerosis	7.47e-05	0.0161	CrCbGaD
Carbamazepine—CYP3A5—Metabolism—ABCA1—atherosclerosis	8.29e-06	0.00014	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—NOS3—atherosclerosis	8.27e-06	0.00014	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.24e-06	0.00014	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—LIPC—atherosclerosis	8.24e-06	0.00014	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.23e-06	0.000139	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—APOC3—atherosclerosis	8.19e-06	0.000139	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—LDLR—atherosclerosis	8.14e-06	0.000138	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—MTHFR—atherosclerosis	8.1e-06	0.000137	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NAMPT—atherosclerosis	8.09e-06	0.000137	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—LPA—atherosclerosis	8.08e-06	0.000137	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HMGCR—atherosclerosis	8.05e-06	0.000136	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—LIPC—atherosclerosis	8.04e-06	0.000136	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—APOC3—atherosclerosis	7.99e-06	0.000135	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CETP—atherosclerosis	7.95e-06	0.000135	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARA—atherosclerosis	7.95e-06	0.000135	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—LDLR—atherosclerosis	7.94e-06	0.000135	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—BGN—atherosclerosis	7.83e-06	0.000133	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.79e-06	0.000132	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.77e-06	0.000132	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CETP—atherosclerosis	7.76e-06	0.000131	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—APOA5—atherosclerosis	7.75e-06	0.000131	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—LCAT—atherosclerosis	7.74e-06	0.000131	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—FABP4—atherosclerosis	7.74e-06	0.000131	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AGT—atherosclerosis	7.7e-06	0.00013	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.62e-06	0.000129	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SCARB1—atherosclerosis	7.61e-06	0.000129	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOA4—atherosclerosis	7.59e-06	0.000129	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—atherosclerosis	7.56e-06	0.000128	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NAMPT—atherosclerosis	7.56e-06	0.000128	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—APOE—atherosclerosis	7.54e-06	0.000128	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.52e-06	0.000128	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.52e-06	0.000127	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—LIPC—atherosclerosis	7.51e-06	0.000127	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CAV1—atherosclerosis	7.47e-06	0.000127	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—APOC3—atherosclerosis	7.47e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	7.46e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	7.46e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—APOA1—atherosclerosis	7.45e-06	0.000126	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SCARB1—atherosclerosis	7.43e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—LDLR—atherosclerosis	7.42e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.41e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.37e-06	0.000125	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.31e-06	0.000124	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.29e-06	0.000123	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—HMOX1—atherosclerosis	7.27e-06	0.000123	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.26e-06	0.000123	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CETP—atherosclerosis	7.25e-06	0.000123	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALOX5—atherosclerosis	7.2e-06	0.000122	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HMGCR—atherosclerosis	7.19e-06	0.000122	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ABCA1—atherosclerosis	7.18e-06	0.000122	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HMOX1—atherosclerosis	7.11e-06	0.00012	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HMGCR—atherosclerosis	7.02e-06	0.000119	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—APOB—atherosclerosis	6.97e-06	0.000118	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SCARB1—atherosclerosis	6.94e-06	0.000118	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	6.9e-06	0.000117	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.88e-06	0.000117	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—APOB—atherosclerosis	6.81e-06	0.000115	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CG—atherosclerosis	6.81e-06	0.000115	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTM1—atherosclerosis	6.78e-06	0.000115	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.76e-06	0.000115	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.65e-06	0.000113	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—LPL—atherosclerosis	6.65e-06	0.000113	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTM1—atherosclerosis	6.62e-06	0.000112	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARG—atherosclerosis	6.57e-06	0.000111	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HMGCR—atherosclerosis	6.55e-06	0.000111	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.54e-06	0.000111	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOA2—atherosclerosis	6.54e-06	0.000111	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.54e-06	0.000111	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.54e-06	0.000111	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—LPL—atherosclerosis	6.5e-06	0.00011	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GPX1—atherosclerosis	6.49e-06	0.00011	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.48e-06	0.00011	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NAMPT—atherosclerosis	6.46e-06	0.000109	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.46e-06	0.000109	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—INS—atherosclerosis	6.44e-06	0.000109	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.42e-06	0.000109	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—LIPC—atherosclerosis	6.42e-06	0.000109	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ABCA1—atherosclerosis	6.41e-06	0.000109	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—APOC3—atherosclerosis	6.38e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GPX1—atherosclerosis	6.34e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—LDLR—atherosclerosis	6.34e-06	0.000107	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CD36—atherosclerosis	6.32e-06	0.000107	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ABCA1—atherosclerosis	6.25e-06	0.000106	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—LPA—atherosclerosis	6.24e-06	0.000106	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CETP—atherosclerosis	6.19e-06	0.000105	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CD36—atherosclerosis	6.18e-06	0.000105	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HMOX1—atherosclerosis	6.16e-06	0.000104	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—BGN—atherosclerosis	6.04e-06	0.000102	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—MTHFR—atherosclerosis	5.99e-06	0.000101	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOA5—atherosclerosis	5.98e-06	0.000101	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SCARB1—atherosclerosis	5.93e-06	0.0001	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.91e-06	0.0001	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ALB—atherosclerosis	5.91e-06	0.0001	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—APOB—atherosclerosis	5.9e-06	0.0001	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARA—atherosclerosis	5.88e-06	9.96e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—MTHFR—atherosclerosis	5.85e-06	9.92e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.84e-06	9.9e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.77e-06	9.78e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.76e-06	9.75e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARA—atherosclerosis	5.74e-06	9.73e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTM1—atherosclerosis	5.74e-06	9.72e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AGT—atherosclerosis	5.69e-06	9.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NOS3—atherosclerosis	5.65e-06	9.57e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—LPL—atherosclerosis	5.63e-06	9.54e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HMGCR—atherosclerosis	5.6e-06	9.49e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—APOE—atherosclerosis	5.58e-06	9.45e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AGT—atherosclerosis	5.56e-06	9.43e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.56e-06	9.42e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CAV1—atherosclerosis	5.53e-06	9.36e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—APOA1—atherosclerosis	5.51e-06	9.34e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HMOX1—atherosclerosis	5.5e-06	9.31e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GPX1—atherosclerosis	5.5e-06	9.31e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—APOE—atherosclerosis	5.45e-06	9.24e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CAV1—atherosclerosis	5.4e-06	9.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—APOA1—atherosclerosis	5.39e-06	9.13e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HMOX1—atherosclerosis	5.37e-06	9.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CD36—atherosclerosis	5.35e-06	9.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—APOB—atherosclerosis	5.27e-06	8.92e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—atherosclerosis	5.17e-06	8.75e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—APOB—atherosclerosis	5.14e-06	8.71e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTM1—atherosclerosis	5.12e-06	8.68e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—MTHFR—atherosclerosis	5.07e-06	8.59e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.05e-06	8.56e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	5.03e-06	8.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—LPL—atherosclerosis	5.03e-06	8.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.01e-06	8.49e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTM1—atherosclerosis	5e-06	8.47e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCA1—atherosclerosis	4.99e-06	8.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.99e-06	8.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARA—atherosclerosis	4.98e-06	8.43e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—LIPC—atherosclerosis	4.95e-06	8.39e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOC3—atherosclerosis	4.92e-06	8.34e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	4.92e-06	8.34e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—LPL—atherosclerosis	4.91e-06	8.31e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GPX1—atherosclerosis	4.9e-06	8.31e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—LDLR—atherosclerosis	4.89e-06	8.29e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARG—atherosclerosis	4.86e-06	8.23e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AGT—atherosclerosis	4.82e-06	8.16e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—APOB—atherosclerosis	4.8e-06	8.13e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GPX1—atherosclerosis	4.79e-06	8.11e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CETP—atherosclerosis	4.78e-06	8.1e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CD36—atherosclerosis	4.78e-06	8.09e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—INS—atherosclerosis	4.76e-06	8.07e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARG—atherosclerosis	4.75e-06	8.04e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—APOE—atherosclerosis	4.72e-06	8e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CAV1—atherosclerosis	4.68e-06	7.93e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.67e-06	7.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—APOA1—atherosclerosis	4.67e-06	7.91e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CD36—atherosclerosis	4.66e-06	7.9e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—INS—atherosclerosis	4.66e-06	7.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—LPL—atherosclerosis	4.58e-06	7.77e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.58e-06	7.76e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—MTHFR—atherosclerosis	4.53e-06	7.67e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GPX1—atherosclerosis	4.47e-06	7.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARA—atherosclerosis	4.44e-06	7.52e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—MTHFR—atherosclerosis	4.42e-06	7.49e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ALB—atherosclerosis	4.37e-06	7.4e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CD36—atherosclerosis	4.36e-06	7.38e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARA—atherosclerosis	4.33e-06	7.34e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.32e-06	7.32e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AGT—atherosclerosis	4.3e-06	7.29e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.28e-06	7.26e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ALB—atherosclerosis	4.27e-06	7.23e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	4.26e-06	7.22e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—APOE—atherosclerosis	4.21e-06	7.14e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AGT—atherosclerosis	4.2e-06	7.11e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NOS3—atherosclerosis	4.18e-06	7.08e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CAV1—atherosclerosis	4.18e-06	7.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—APOA1—atherosclerosis	4.17e-06	7.06e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.13e-06	6.99e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—APOE—atherosclerosis	4.11e-06	6.97e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARG—atherosclerosis	4.11e-06	6.97e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—APOB—atherosclerosis	4.1e-06	6.95e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NOS3—atherosclerosis	4.08e-06	6.92e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CAV1—atherosclerosis	4.08e-06	6.91e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—APOA1—atherosclerosis	4.07e-06	6.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARA—atherosclerosis	4.05e-06	6.86e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—INS—atherosclerosis	4.03e-06	6.83e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.99e-06	6.76e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AGT—atherosclerosis	3.92e-06	6.64e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—LPL—atherosclerosis	3.92e-06	6.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.85e-06	6.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—APOE—atherosclerosis	3.84e-06	6.51e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.82e-06	6.48e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—atherosclerosis	3.82e-06	6.47e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.81e-06	6.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.8e-06	6.44e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—atherosclerosis	3.8e-06	6.44e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.8e-06	6.44e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—atherosclerosis	3.73e-06	6.33e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CD36—atherosclerosis	3.72e-06	6.31e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.71e-06	6.29e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALB—atherosclerosis	3.7e-06	6.27e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARG—atherosclerosis	3.67e-06	6.22e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—INS—atherosclerosis	3.6e-06	6.1e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARG—atherosclerosis	3.58e-06	6.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NOS3—atherosclerosis	3.54e-06	5.99e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.53e-06	5.98e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—INS—atherosclerosis	3.51e-06	5.95e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.47e-06	5.88e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARA—atherosclerosis	3.46e-06	5.86e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AGT—atherosclerosis	3.35e-06	5.68e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARG—atherosclerosis	3.35e-06	5.67e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.31e-06	5.6e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALB—atherosclerosis	3.3e-06	5.59e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—APOE—atherosclerosis	3.28e-06	5.56e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—INS—atherosclerosis	3.28e-06	5.56e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CAV1—atherosclerosis	3.25e-06	5.51e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—APOA1—atherosclerosis	3.25e-06	5.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.23e-06	5.48e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALB—atherosclerosis	3.22e-06	5.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOB—atherosclerosis	3.17e-06	5.36e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NOS3—atherosclerosis	3.16e-06	5.35e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NOS3—atherosclerosis	3.08e-06	5.22e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.08e-06	5.22e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—LPL—atherosclerosis	3.02e-06	5.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALB—atherosclerosis	3.01e-06	5.1e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.96e-06	5.02e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.95e-06	5e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.89e-06	4.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.88e-06	4.88e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CD36—atherosclerosis	2.87e-06	4.87e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.86e-06	4.85e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.82e-06	4.78e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—INS—atherosclerosis	2.81e-06	4.75e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.72e-06	4.61e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.67e-06	4.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.63e-06	4.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—atherosclerosis	2.6e-06	4.4e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AGT—atherosclerosis	2.59e-06	4.38e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALB—atherosclerosis	2.57e-06	4.36e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOE—atherosclerosis	2.53e-06	4.29e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.51e-06	4.25e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.51e-06	4.24e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NOS3—atherosclerosis	2.46e-06	4.17e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.29e-06	3.88e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.25e-06	3.81e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.21e-06	3.74e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—INS—atherosclerosis	2.16e-06	3.67e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALB—atherosclerosis	1.98e-06	3.36e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.92e-06	3.25e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.9e-06	3.22e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—atherosclerosis	1.88e-06	3.18e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.74e-06	2.94e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.63e-06	2.75e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.45e-06	2.46e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—atherosclerosis	1.42e-06	2.4e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.32e-06	2.24e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.13e-06	1.92e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—atherosclerosis	8.73e-07	1.48e-05	CbGpPWpGaD
